Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE


By Author Proscia | January 20, 2021

The National Cancer Institute Consortium for Molecular Characterization of Screen-Detected Lesions and NASA Jet Propulsion Laboratory, coordinated by the Baylor College of Medicine, have deployed Proscia’s Concentriq digital and computational pathology platform in their efforts to address cancer overdiagnosis.

The NASA laboratory is digitizing a repository of pathology data for researchers in the NCI consortium and will use Proscia’s Concentriq image- and data-management platform to host and manage the repository. Concentriq will centralize the activities of the consortium’s seven sites to support collaboration and data sharing

Our website uses cookies. By using this site, you agree to its use of cookies.